These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10937738)

  • 21. Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles.
    Ranatunge RR; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Young DV; Zemetseva IS
    Bioorg Med Chem; 2004 Mar; 12(6):1357-66. PubMed ID: 15018908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors.
    Dubé D; Brideau C; Deschênes D; Fortin R; Friesen RW; Gordon R; Girard Y; Riendeau D; Savoie C; Chan CC
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1715-20. PubMed ID: 10397507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of (E)- and (Z)-styryl-2-acetoxyphenyl sulfides and sulfones as cyclooxygenase-2 inhibitors.
    Reddy MV; Mallireddigari MR; Pallela VR; Venkatapuram P; Boominathan R; Bell SC; Reddy EP
    Bioorg Med Chem; 2005 Mar; 13(5):1715-23. PubMed ID: 15698789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibitors.
    Nies AS; Gresser MJ
    Adv Protein Chem; 2001; 56():115-41. PubMed ID: 11329851
    [No Abstract]   [Full Text] [Related]  

  • 27. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.
    Hashimoto H; Maeda K; Ozawa K; Haruta J; Wakitani K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):65-8. PubMed ID: 11738574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring selectivity requirements for COX-2 versus COX-1 binding of 3,4-diaryloxazolones using E-state index.
    Roy K; Chakraborty S; Saha A
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3753-7. PubMed ID: 14552773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantiospecific, selective cyclooxygenase-2 inhibitors.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Marnett LJ
    Bioorg Med Chem Lett; 2002 May; 12(9):1315-8. PubMed ID: 11965379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogs.
    Pinto DJ; Batt DG; Pitts WJ; Petraitis JJ; Orwat MJ; Wang S; Jetter JW; Sherk SR; Houghton GC; Copeland RA; Covington MB; Trzaskos JM; Magolda RL
    Bioorg Med Chem Lett; 1999 Apr; 9(7):919-24. PubMed ID: 10230611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformationally restricted 3,4-diarylfuranones (2,3a,4,5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors.
    Pal M; Rao Veeramaneni V; Nagabelli M; Rao Kalleda S; Misra P; Rao Casturi S; Rao Yeleswarapu K
    Bioorg Med Chem Lett; 2003 May; 13(10):1639-43. PubMed ID: 12729631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Knaus EE
    Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors.
    Carter JS; Kramer S; Talley JJ; Penning T; Collins P; Graneto MJ; Seibert K; Koboldt CM; Masferrer J; Zweifel B
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1171-4. PubMed ID: 10328307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors.
    Feixas J; Jiménez JM; Godessart N; Puig C; Soca L; Crespo MI
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2687-90. PubMed ID: 11591502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere.
    Habeeb AG; Praveen Rao PN; Knaus EE
    J Med Chem; 2001 Aug; 44(18):3039-42. PubMed ID: 11520213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
    Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG
    J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.